National Institute on Drug Abuse; Notice of Meeting

• Published date: 28 March 2024
• Record Number: 2024-06612
• Citation: 89 FR 21526
• Court: National Institutes Of Health
• Section: Notices

Federal Register, Volume 89 Issue 61 (Thursday, March 28, 2024)

[Federal Register Volume 89, Number 61 (Thursday, March 28, 2024)]
                [Notices]
                [Page 21526]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2024-06612]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Meeting
                 Pursuant to section 1009 of the Federal Advisory Committee Act, as
                amended, notice is hereby given of a meeting of the National Advisory
                Council on Drug Abuse.
                 This will be a hybrid meeting held in-person and virtually and will
                be open to the public, as indicated below, with attendance limited to
                space available. Individuals who plan to attend in-person or view the
                virtual meeting and need special assistance such as sign language
                interpretation or other reasonable accommodations, should notify Dr.
                Jeanette Marketon via email at [email protected] five days in
                advance of the meeting. The open session of the meeting can be accessed
                from the NIH Videocast at the following link: https://videocast.nih.gov/.
                 A portion of the meeting will be closed to the public in accordance
                with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
                Title 5 U.S.C., as amended. The grant applications and the discussions
                could disclose confidential trade secrets or commercial property such
                as patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Advisory Council on Drug Abuse.
                 Date: May 7, 2024.
                 Closed: 10:30 a.m. to 11:45 a.m.
                 Agenda: To review and evaluate grant applications.
                 Open: 12:45 p.m. to 5:00 p.m.
                 Agenda: Presentations and other business of the Council.
                 Place: Neuroscience Center, Conference Room 1155/1145, National
                Institutes of Health, 6001 Executive Boulevard, Rockville, MD 20852
                (Hybrid Meeting).
                 Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of
                Extramural Research, Office of the Director, National Institute on
                Drug Abuse, NIH, Three White Flint North, RM 09D08, 11601 Landsdown
                Street, Bethesda, MD 20852, 301-443-6480, [email protected].
                 Contact Person: Jeanette Marketon, Ph.D., PMP Director, Office
                of Extramural Policy. Division of Extramural Research, Office of
                Extramural Policy, National Institute on Drug Abuse, NIH, Three
                White Flint North, RM 09C71, 11601 Landsdown Street, Bethesda, MD
                20852, 301-443-5239, [email protected].
                 Any interested person may file written comments with the committee
                by forwarding the statement to Dr. Jeanette Marketon via email at
                [email protected]. The statement should include the name,
                address, telephone number and when applicable, the business or
                professional affiliation of the interested person.
                 In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
                entrance into on-campus and off-campus facilities. All visitor
                vehicles, including taxicabs, hotel, and airport shuttles will be
                inspected before being allowed on campus. Visitors attending a meeting
                on campus or at an off-campus federal facility will be asked to show
                one form of identification (for example, a government-issued photo ID,
                driver's license, or passport) and to state the purpose of their visit.
                 Information is also available on the Institute's/Center's home
                page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and any
                additional information for the meeting will be posted when available.
                (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
                Abuse Scientist Development Award for Clinicians, Scientist
                Development Awards, and Research Scientist Awards; 93.278, Drug
                Abuse National Research Service Awards for Research Training;
                93.279, Drug Abuse and Addiction Research Programs, National
                Institutes of Health, HHS)
                 Dated: March 25, 2024.
                Lauren A. Fleck,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2024-06612 Filed 3-27-24; 8:45 am]
                BILLING CODE 4140-01-P